Psychiatry News

Quolet Industries has announced the completion of a phase 1 study evaluating a novel, lipid formulation of pure CBD as a potential treatment for various psychiatric and neurologic conditions.

The elevated propensity for peripheral artery disease in patients with major depression may be mediated by increased liability for lifetime smoking and BMI, according to research in the Journal of the American Heart Association.

WASHINGTON — Food allergies, particularly when combined with asthma, were associated with higher odds of mental health disorders and physical diseases in addition to higher health care use, researchers found.

Individuals with vision impairment have greater odds of experiencing symptoms of depression, anxiety and social isolation, according to new research published in JAMA Ophthalmology.

Individuals with mania who were admitted to an acute care psychiatric unit saw greater sleep improvement than patients with major depressive disorder, according to a study.

U.S. policy changes are needed to reduce perinatal mental health deserts, standardize social determinants of health data, improve psychiatric curriculums and establish paid parental leave, researchers reported in JAMA Psychiatry.

Patients hospitalized for depression appeared at greatest risk for suicide within the first week after discharge, according to a study conducted in Finland and published in JAMA Psychiatry.

Kathryn P. L. Moore, MD, MSc, assistant professor of neurology at Duke University School of Medicine, discusses therapies in the pipeline that are working to target the cause of Huntington's disease.

Kathryn P. L. Moore, MD, MSc, assistant professor of neurology at Duke University School of Medicine, discusses valbenazine, a recent approval in Huntington's disease care.

Kathryn P. L. Moore, MD, MSc, assistant professor of neurology at Duke University School of Medicine, discusses risk factors that can be addressed early in Huntington's disease treatment, such as smoking and excessive alcohol intake.